March 2013 – content
Life Sciences
Illumina sued over its rejection of Roche bid
Lonza restructures business units
BioCision raises funds for growth
Labcyte raises funds for portfolio expansion
Illumina sells stake in deCode Genetics
Sphere Fluidics raises additional funds
Avia seeks partners for isothermal formulation testing platform
Affymetrix signs license agreement
Stratos Genomics achieves technical milestone
General Laboratory
Nanoink closes doors
Techcomp expands European foothold with acquisition
ICL finalises integration of FTIR gas-cell company
Anton Paar opens direct offices
Eurofins makes 11 purchases in 12 months
Konica buys light testing companies
HORIBA in collaboration targeting drug formulations
Quantachrome Japan opens doors
Halma restructures business
Process & hand-held instrumentation
Life Tech expand capabilities in affinity purification
Sartorius signs exclusive agreement on in-line biosensors
OI re-signs Canadian partner
Features
2012 M&A activities increase, but transaction prices decrease
US record lowest growth since the crisis
Financials
Life Science firms beat estimates in strong Q4
Bio-Rad beats despite fall in profits
Ion Torrent boosts Life Tech
Affymetrix to cut costs and jobs after solid Q4
Illumina boosted by unit sale
Diagnostics drive Danaher LSD
Luminex tops estimates
Many lab firms impress in Q4 but worries remain
Thermo Fisher grows diagnostics
Weak EU holds back MT
FEI beats despite life science slide
Waters positive after sluggish year
Agilent stock dips on earnings
Bruker surges on revenue beat
PerkinElmer narrow losses
Cost-cutting improves profitability for process firms
Danaher grows on water analysis and Chinese acquisition
Acquisitions boos Teledyne
Newly streamlined FLIR returns to profit
Xylem sinks on sluggish markets
Ametek stock jumps on record Q4
Grace stock hits all-time high
Appointments